Skip to main content

Stereotaxis, Inc. (STXS) Stock Forecast 2025 - AI Price Prediction & Analysis


Stereotaxis, Inc. (STXS) AI Stock Price Forecast & Investment Analysis

Stereotaxis, Inc. Stock Price Chart and Technical Analysis

Loading Stereotaxis, Inc. interactive price chart and technical analysis...

Stereotaxis, Inc. (STXS) - Comprehensive Stock Analysis & Investment Research

Deep dive into Stereotaxis, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Stereotaxis, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Stereotaxis, Inc.: Stereotaxis, Inc. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

Stereotaxis, Inc. (Stock Symbol: STXS) is a leading company in the Industrial Applications and Services sector , specifically operating within the Electromedical & Electrotherapeutic Apparatus industry.

The organization employs approximately 182 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Stereotaxis, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Stereotaxis, Inc.: With $31M in annual revenue and -309.4% net margin, the company demonstrates developing profitability.

Annual Revenue: $31 million generating a -309.4% net profit margin .

Market Capitalization: $1182 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -43.6% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Stereotaxis, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Stereotaxis, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Stereotaxis, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Stereotaxis, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Stereotaxis, Inc.: Market positioning analysis based on available financial and operational metrics.

Stereotaxis, Inc. strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 202.5% gross margin, indicating strong pricing power and operational efficiency.

Stereotaxis, Inc. (STXS) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Stereotaxis, Inc. stock analysis.

Loading Stereotaxis, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Stereotaxis, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Stereotaxis, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Stereotaxis, Inc.: With a P/E ratio of -8.43, the market sees the stock as potentially undervalued.

P/E Ratio -8.43x
P/B Ratio 811.53x
Market Cap $1182M
EPS $-0.29
Revenue/Share $0.08
FCF/Share $-0.08
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Stereotaxis, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Stereotaxis, Inc.: An ROE of -43.6% indicates room for improvement in shareholder value creation.

ROE -43.6%
ROA -25.1%
ROIC -37.9%
Gross Margin 202.5%
Operating Margin -321.5%
Net Margin -309.4%
EBT Margin -39.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Stereotaxis, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Stereotaxis, Inc.: A current ratio of 4.10 indicates strong liquidity.

Current Ratio 4.10x
Quick Ratio 3.46x
D/E Ratio 0.18x
Financial Leverage 1.78x
Interest Coverage -9.1x
Working Capital $39M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Stereotaxis, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Stereotaxis, Inc.: Free cash flow of $-7M indicates cash challenges that need attention.

Operating Cash Flow $-5M
Free Cash Flow $-7M
Capital Spending $-3M
FCF/Sales -22.0%
CapEx/Sales 7.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Stereotaxis, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Stereotaxis, Inc.: An asset turnover of 0.58x suggests room for improvement in asset utilization.

Asset Turnover 0.58x
Receivables Turnover 5.6x
Inventory Turnover 2.7x
Fixed Assets Turnover 6.2x
Days Sales Outstanding 65 days
Days Inventory 136 days
Payables Period 83 days
Cash Conversion Cycle 118 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Stereotaxis, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Stereotaxis, Inc.: With annual revenue of $31M, Stereotaxis, Inc. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $31M
R&D Expense $9M
SG&A Expense $82M
Cost of Goods Sold $-3M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 82%
Cash & Short-term Investments 61%
Total Liabilities 34%
Short-term Debt 2%
Accounts Receivable 8%
Inventory 8%
Dividend & Shareholder Information
Shares Outstanding 407M
Growth Metrics (YoY)
EPS Growth -9.4%

Latest Stereotaxis, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Stereotaxis, Inc. (STXS) stock price and investment outlook.

, source: Yahoo Finance

Earnings call Stereotaxis reported Q1 2025 revenue of $7.5M, up 9% YoY, with recurring revenue growing 28% YoY to $5.5M. The company reiterated full-year double-digit growth guidance, driven by MAPIT ...

, source: MarketWatch

Stereotaxis Inc. Annual stock financials by MarketWatch. View the latest RJR1 financial statements, income statements and financial ratios.

, source: Seeking Alpha

Good afternoon, and welcome to the Stereotaxis, Inc. Second Quarter 2024 Earnings Conference Call. Certain statements during the call and question-and-answer period to follow may relate to future ...

, source: Seeking Alpha

Good morning. Thank you for joining us for Stereotaxis Fourth Quarter and Full Year 2022 Earnings Conference Call. Certain statements during the conference call and question-and-answer period to ...

, source: Reuters

Jan 15 (Reuters) - Medical device maker Stereotaxis Inc forecast quarterly revenue below analysts' view, due to delayed launches of its catheter device for the heart in Europe and the United States, ...

Stereotaxis, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Stereotaxis, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AXGN Unlock Forecast - 30 Days FREE Trial $751M -41.7x 6.7x
BLFS Unlock Forecast - 30 Days FREE Trial $991M -14.7x 2.8x
BSGM Unlock Forecast - 30 Days FREE Trial $126M -1.8x 48.5x
CBLL Unlock Forecast - 30 Days FREE Trial $438M x 2.5x
CNMD Unlock Forecast - 30 Days FREE Trial $1644M 14.9x 1.6x
CUTR Unlock Forecast - 30 Days FREE Trial $9M -0.1x 0.0x
CV Unlock Forecast - 30 Days FREE Trial $0M x x
ECOR Unlock Forecast - 30 Days FREE Trial $37M -7.3x 32.8x
EDAP Unlock Forecast - 30 Days FREE Trial $99M x 2.4x
ELMD Unlock Forecast - 30 Days FREE Trial $218M 28.9x 5.1x
FONR Unlock Forecast - 30 Days FREE Trial $99M 9.5x 0.6x
GTHP Unlock Forecast - 30 Days FREE Trial $22M x x
HSDT Unlock Forecast - 30 Days FREE Trial $66M 0.0x 51.9x
HYPR Unlock Forecast - 30 Days FREE Trial $148M -1.8x 0.9x
INMD Unlock Forecast - 30 Days FREE Trial $1211M x 1.7x
IRIX Unlock Forecast - 30 Days FREE Trial $24M -2.8x 3.9x
IRME Unlock Forecast - 30 Days FREE Trial $1M x x
ITGR Unlock Forecast - 30 Days FREE Trial $3741M 45.3x 2.2x
LIVN Unlock Forecast - 30 Days FREE Trial $3141M -662.0x 2.8x
MASI Unlock Forecast - 30 Days FREE Trial $8132M 128.1x 7.8x
MDT Unlock Forecast - 30 Days FREE Trial $119421M 25.6x 2.5x
MOVE Unlock Forecast - 30 Days FREE Trial $5M -8.6x 0.7x
NDRA Unlock Forecast - 30 Days FREE Trial $2M -0.8x 1.1x
NRXS Unlock Forecast - 30 Days FREE Trial $24M -0.9x 5.6x
NUWE Unlock Forecast - 30 Days FREE Trial $65M -0.1x 18.1x
NXL Unlock Forecast - 30 Days FREE Trial $15M -4.7x 2.4x
NXLIW Unlock Forecast - 30 Days FREE Trial $5M x 1.0x
OM Unlock Forecast - 30 Days FREE Trial $249M -0.4x 1.6x
POCI Unlock Forecast - 30 Days FREE Trial $36M -11.5x 2.8x
QTI Unlock Forecast - 30 Days FREE Trial $7M -0.4x -0.8x
SLNO Unlock Forecast - 30 Days FREE Trial $4417M -18.5x 19.0x
SMLR Unlock Forecast - 30 Days FREE Trial $385M 10.4x 1.0x
STRR Unlock Forecast - 30 Days FREE Trial $7M -1.6x 0.1x
STRRP Unlock Forecast - 30 Days FREE Trial $31M -5.5x 0.5x
STXS Unlock Forecast - 30 Days FREE Trial $1182M -8.4x 811.5x
TIVC Unlock Forecast - 30 Days FREE Trial $3M 0.0x 0.8x
TMDX Unlock Forecast - 30 Days FREE Trial $4357M 60.8x 13.7x
VANI Unlock Forecast - 30 Days FREE Trial $92M -2.7x 7.9x
VASO Unlock Forecast - 30 Days FREE Trial $21M 20.1x 0.8x
ZYXI Unlock Forecast - 30 Days FREE Trial $46M 41.4x 36.5x

Frequently Asked Questions - Stereotaxis, Inc. Stock Forecast

How accurate are Stereotaxis, Inc. stock predictions?

Our AI model demonstrates 50% historical accuracy for STXS predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Stereotaxis, Inc. stock price forecasts?

Our analysis considers Stereotaxis, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Stereotaxis, Inc. a good investment in 2025?

Based on our AI analysis, Stereotaxis, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Stereotaxis, Inc. forecasts updated?

Stereotaxis, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Stereotaxis, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Stereotaxis, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...